ENANTA PHARMACEUTICALS INC (ENTA) Stock Analyst Earnings Estimates
NASDAQ:ENTA - Nasdaq - US29251M1062 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 86.2M -11.23% | 79.2M -8.12% | 67.635M -14.60% | 63.987M -5.39% | 52.198M -18.42% | 38.183M -26.85% | 59.682M 56.31% | 79.769M 33.66% | 270.81M 239.49% | 118.32M -56.31% | 128.52M 8.62% | |
| EBITDA YoY % growth | -120.83M -13.70% | -134.83M -11.59% | -119.355M 11.48% | -133.62M -11.95% | -169.32M -26.72% | -178.5M -5.42% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -123.8M -12.96% | -137.2M -10.82% | -121.691M 11.30% | -111.182M 8.64% | -131.753M -18.50% | -134.003M -1.71% | -121.661M 9.21% | -106.319M 12.61% | 1.02M 100.96% | 15.3M 1,400.00% | 32.64M 113.33% | |
| Operating Margin | -143.62% | -173.23% | -179.92% | -173.76% | -252.41% | -350.95% | -203.85% | -133.28% | 0.38% | 12.93% | 25.40% | |
| EPS YoY % growth | -5.91 -51.15% | -6.37 -7.78% | -5.48 13.97% | -4.34 20.77% | -4.71 -8.59% | -4.51 4.45% | -9.22 -104.68% | -8.24 10.62% | 0.81 109.78% | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -1.17 20.38% | -1.25 -16.54% | -1.28 6.06% |
| Revenue Q2Q % growth | 16.259M -4.66% | 15.926M -11.38% | 14.472M -0.92% |
| EBITDA Q2Q % growth | -22.44M 28.77% | -20.4M 8.63% | -24.48M 11.04% |
| EBIT Q2Q % growth | -26.9M 17.90% | -29.243M -20.91% | -32.264M -8.07% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -1.05 33.54% | -1.38 | 0.33 | 23.90% |
| Q4 2024 Q2Q % growth | -1.36 -2.26% | -1.18 | -0.18 | -14.94% |
| Q3 2024 Q2Q % growth | -1.07 42.47% | -1.48 | 0.41 | 27.64% |
| Q2 2024 Q2Q % growth | -1.47 17.88% | -1.32 | -0.15 | -11.01% |
| Q1 2024 Q2Q % growth | -1.58 -13.67% | -1.22 | -0.36 | -29.73% |
| Q4 2023 Q2Q % growth | -1.33 -4.72% | -2.19 | 0.86 | 39.26% |
| Q3 2023 Q2Q % growth | -1.86 -21.57% | -2.38 | 0.52 | 21.99% |
| Q2 2023 Q2Q % growth | -1.79 -9.82% | -2.02 | 0.23 | 11.37% |
| Q1 2023 Q2Q % growth | -1.39 6.08% | -1.63 | 0.24 | 14.56% |
| Q4 2022 Q2Q % growth | -1.27 -4.10% | -1.38 | 0.11 | 7.94% |
| Q3 2022 Q2Q % growth | -1.53 -28.57% | -1.41 | -0.12 | -8.21% |
| Q2 2022 Q2Q % growth | -1.63 -49.54% | -1.45 | -0.18 | -12.10% |
| Q1 2022 Q2Q % growth | -1.48 -260.98% | -1.10 | -0.38 | -34.19% |
| Q4 2021 Q2Q % growth | -1.22 16.44% | -1.25 | 0.03 | 2.14% |
| Q3 2021 Q2Q % growth | -1.19 -67.61% | -1.30 | 0.11 | 8.77% |
| Q2 2021 Q2Q % growth | -1.09 -263.33% | -1.00 | -0.09 | -8.82% |
| Q1 2021 Q2Q % growth | -0.41 -163.08% | -0.75 | 0.34 | 45.68% |
| Q4 2020 Q2Q % growth | -1.46 -431.82% | -0.97 | -0.49 | -49.99% |
| Q3 2020 Q2Q % growth | -0.71 -315.15% | -0.86 | 0.15 | 17.62% |
| Q2 2020 Q2Q % growth | -0.30 -250.00% | -0.91 | 0.61 | 67.04% |
| Q1 2020 Q2Q % growth | 0.65 -48.00% | 0.56 | 0.09 | 16.71% |
| Q4 2019 Q2Q % growth | 0.44 | 0.54 | -0.10 | -18.41% |
| Q3 2019 Q2Q % growth | 0.33 | 0.17 | 0.16 | 97.96% |
| Q2 2019 Q2Q % growth | 0.20 | -0.08 | 0.28 | 349.56% |
| Q1 2019 Q2Q % growth | 1.25 | 1.37 | -0.12 | -9.03% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 16.959M -5.80% | 17.594M | -635K | -3.61% |
| Q4 2024 Q2Q % growth | 14.607M -22.84% | 18.291M | -3.684M | -20.14% |
| Q3 2024 Q2Q % growth | 17.971M -4.88% | 17.522M | 449K | 2.56% |
| Q2 2024 Q2Q % growth | 17.054M -4.16% | 16.416M | 638K | 3.89% |
| Q1 2024 Q2Q % growth | 18.003M -23.68% | 21.708M | -3.705M | -17.07% |
| Q4 2023 Q2Q % growth | 18.932M -6.83% | 17.848M | 1.084M | 6.07% |
| Q3 2023 Q2Q % growth | 18.892M -3.02% | 18.419M | 473K | 2.57% |
| Q2 2023 Q2Q % growth | 17.795M -4.94% | 19.566M | -1.771M | -9.05% |
| Q1 2023 Q2Q % growth | 23.59M -14.68% | 23.02M | 570K | 2.48% |
| Q4 2022 Q2Q % growth | 20.32M -13.83% | 23.319M | -2.999M | -12.86% |
| Q3 2022 Q2Q % growth | 19.48M -9.90% | 21.114M | -1.634M | -7.74% |
| Q2 2022 Q2Q % growth | 18.72M -7.00% | 21.084M | -2.364M | -11.21% |
| Q1 2022 Q2Q % growth | 27.65M -12.89% | 27.906M | -256K | -0.92% |
| Q4 2021 Q2Q % growth | 23.58M -0.21% | 26.869M | -3.289M | -12.24% |
| Q3 2021 Q2Q % growth | 21.62M 15.92% | 22.298M | -678K | -3.04% |
| Q2 2021 Q2Q % growth | 20.13M -27.12% | 24.864M | -4.734M | -19.04% |
| Q1 2021 Q2Q % growth | 31.74M -39.62% | 29.367M | 2.373M | 8.08% |
| Q4 2020 Q2Q % growth | 23.63M -53.95% | 26.26M | -2.63M | -10.02% |
| Q3 2020 Q2Q % growth | 18.65M -57.97% | 26.843M | -8.193M | -30.52% |
| Q2 2020 Q2Q % growth | 27.62M -30.31% | 27.856M | -236K | -0.85% |
| Q1 2020 Q2Q % growth | 52.57M -24.78% | 59.231M | -6.661M | -11.25% |
| Q4 2019 Q2Q % growth | 51.31M | 57.06M | -5.75M | -10.08% |
| Q3 2019 Q2Q % growth | 44.37M | 47.923M | -3.553M | -7.41% |
| Q2 2019 Q2Q % growth | 39.63M | 41.699M | -2.069M | -4.96% |
| Q1 2019 Q2Q % growth | 69.89M | 72.694M | -2.804M | -3.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -6.7% | -6.1% | 8.45% | 11.72% |
| Revenue | -4.17% | -8.73% | 0% | -4.26% |